Clinical Trials Directory

Trials / Conditions / Recurrent Epithelial Ovarian Cancer

Recurrent Epithelial Ovarian Cancer

8 registered clinical trials studyying Recurrent Epithelial Ovarian Cancer — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedStudy to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Soli
NCT05700669
Valerio TherapeuticsPhase 1 / Phase 2
RecruitingSalvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer
NCT05444270
Yonsei UniversityN/A
Active Not RecruitingA Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive R
NCT05335993
CanariaBio Inc.Phase 2
UnknownStudy of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
NCT02785250
ImmunoVaccine Technologies, Inc. (IMV Inc.)Phase 1 / Phase 2
CompletedTivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT01853644
Northwestern UniversityPhase 2
CompletedFeasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients
NCT01815528
JSehouliPhase 2
CompletedVeliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation
NCT01472783
Vejle HospitalPhase 1 / Phase 2
TerminatedTrial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients
NCT01334047
Steinar AamdalPhase 1 / Phase 2